Blood and lymphatic vessels in fetuses with increased nuchal translucency at 11-14 weeks' gestation: A review;Blut- und lymphgefäße bei feten mit erhöhter nackentransparenz von 11-14 schwangerschaftswochen: Ein review

Geburtshilfe und Frauenheilkunde

Volumn 64, Issue 11, 2004, Pages 1167-1176

  Von Kaisenberg, C S ^a,b,c   Nicolaides, K H ^b   Brand Saberi, B ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Extracellular matrix; Gene dosis effect; Lymph vessels; Nuchal translucency; Pathophysiology blood vessels

Indexed keywords

CHONDROITIN SULFATE; COLLAGEN; FREE RADICAL; GLYCOPROTEIN; GROWTH FACTOR; HYALURONIC ACID; MATRIX PROTEIN; POLYMER; PROTEOGLYCAN; SUPEROXIDE DISMUTASE; WATER;

ANEUPLOIDY; BLOOD VESSEL; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CHROMOSOME 13; CHROMOSOME 21; CONNECTIVE TISSUE; ECHOGRAPHY; EDEMA; EXTRACELLULAR MATRIX; FETUS ECHOGRAPHY; FIBER; GENETIC DISORDER; GENETIC REGULATION; GESTATION PERIOD; HEART DISEASE; HUMAN; INTERSTITIAL EDEMA; LYMPH VESSEL; NERVE FIBER; NEURAL CREST CELL; PATHOPHYSIOLOGY; REVIEW; SKELETON MALFORMATION; TENSILE STRENGTH; TRISOMY; TURNER SYNDROME;

EID: 9144223186     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-821087     Document Type: Review

References (41)

1. Hyett JA, Moscoso G, Nicolaides KH. Morphometric analysis of the great vessels in early fetal life. Hum Reprod 1995a; 10: 3045-3048
2. Hyett JA, Moscoso G, Nicolaides KH. Increased nuchal translucency in trisomy 21 fetuses: relation to narrowing of the aortic isthmus. Hum Reprod 1995b; 10: 3049-3051
3. Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 1996; 4: 245-250
4. Hyett J, Moscoso G, Nicolaides K. Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses. Am J Med Genet 1997; 69: 207-216
5. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998; 352: 343-346
6. von Kaisenberg CS, Hyett JA. Chapter 3: Pathophysiology of increased nuchal translucency. In: Nicolaides KH, Sebire NJ, Snijders RJM (Series editor: Nicolaides KH). The 11-14 Week Scan. London: The Parthenon Publishing Group, 1999: 95-110
7. Clark EB. Neck web and congenital heart defects: a pathogenic association in 45 X-O Turner syndrome? Teratology 1984; 29: 355-361
8. Miyabara S, Sugihara H, Maehara N, Shouno H, Tasaki H, Yoshida K, Saito N, Kayama F, Ibara S, Suzumori K. Significance of cardiovascular malformations in cystic hygroma: a new interpretation of the pathogenesis. Am J Med Genet 1989; 34: 489-501
9. Besson WT, Kirby ML, Van Mierop LH, Teabeaut JR. Effects of the size of lesions of the cardiac neural crest at various embryonic ages on incidence and type of cardiac defects. Circulation 1986; 73: 360-364
10. Halford S, Wadey R, Roberts C, Daw SC, Whiting JA, O'Donnell H, Dunham I, Bentley D, Lindsay E, Baldini A et al. Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. Hum Mol Genet 1993; 2: 2099-2107
11. von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B. Morphological classification of nuchal skin in fetuses with trisomy 21, 18 and 13 at 12-18 weeks and in a trisomy 16 mouse. Anat Embryol 1998; 197: 105-124
12. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999; 318: 81-85
13. Zosmer N, Souter VL, Chan CS, Huggon IC, Nicolaides KH. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynaecol 1999; 106: 829-833
14. Ghi T, Huggon IC, Zosmer N, Nicolaides KH. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001; 18: 610-614
15. Bronshtein M, Zimmer EZ. The sonographic approach to the detection of fetal cardiac anomalies in early pregnancy. Ultrasound Obstet Gynecol 2002; 19: 360-365
16. Simpson JM, Sharland GK. Nuchal translucency and congenital heart defects: heart failure or not? Ultrasound Obstet Gynecol 2000; 16: 30-36
17. Galindo A, Comas C, Martinez JM, Gutierrez-Larraya F, Carrera JM, Puerto B, Borrell A, Mortera C, de la Fuente P. Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation. J Matern Fetal Neonatal Med 2003; 13: 163-170
18. Huggon IC, DeFigueiredo DB, Allan LD. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart 2003; 89: 1071-1073
19. Hyett JA, Brizot ML, von Kaisenberg CS, McKie AT, Farzaneh F, Nicolaides KH. Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses. Obstet Gynecol 1996; 87: 506-510
20. Montenegro N, Matias A, Areias JC, Castedo S, Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10: 265-268
21. Rizzo G, Muscatello A, Angelini E, Capponi A. Abnormal cardiac function in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 2003; 21: 539-542
22. Salomon LJ, Bernard JP, Taupin P, Benard C, Ville Y. Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 636-643
23. Van der Putte SCJ, Van Limborogh J. The embryonic development of the main lymphatics in man. Acta Morphol Neerl-Scand 1980; 18: 323-335
24. Van der Putte SCJ. Lymphatic malformation in human fetuses. Virchows Arch [A] 1977; 376: 233-246
25. Chitayat D, Kalousek DK, Bamforth JS. Lymphatic abnormalities in fetuses with posterior cervical cystic hygroma. Am J Med Genet 1989; 33: 352-356
26. Vittay P, Bosze P, Gaal M, Laszlo J. Lymph vessel defects in patients with ovarian dysgenesis. Clin Genet 1980; 18: 387-391
27. von Kaisenberg CS, Nicolaides KH, Brand-Saberi B. Lymphatic vessel hypoplasia in fetuses with Turner syndrome. Hum Reprod 1999; 14: 823-826
28. von Kaisenberg CS, Nicolaides KH, Christ B, Meinhold-Heerlein I, Brand-Saberi B. Distribution of lymphatics and blood vessels in the nuchal skin of aneuploid fetuses. Anat Embryol 2004, submitted
29. Tamagnone L, Lahtinen I, Mustonen T, Virtaneva K, Francis F, Muscatelli F, Alitalo R, Smith CIE, Larsson C, Alitalo K. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 1994; 9: 3683-3688
30. Rodriguez-Niedenfuhr M, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Tomarev SI, Wilting J. Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol 2001; 204: 399-406
31. Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J, Stark G, Alitalo K, Tomarev SJ, Niemayer C, Rossker J. The transcription factor Prox1 is a marker of lymphatic endothelial cells in normal and diseased human fetuses. FASEB J 2002; 16: 1271-1273
32. Souka AP, Krampl E, Geerts L, Nicolaides KH. Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation. Prenat Diagn 2002; 22: 91-92
33. Evans AL, Brice G, Sotirova V, Mortimer P, Beninson J, Burnand K, Rosbotham J, Child A, Sarfarazi M. Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet 1999; 64: 547-555
34. Irrthum A, Karkkainen M, Devriendt K, Alitalo K, Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR 3 tyrosine kinase. Am J Hum Genet 2000; 67: 295-301
35. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, Mc Tigue MA, Alitalo K, Finegold DN. Missense mutations interfere with VEGFR-3 signalling in primary lymphedema. Nat Genet 2000; 25: 153-159
36. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995; 92: 3566-3570
37. Ayad S, Boot-Handford RP, Humphries MJ, Kadler KE, Shuttleworth CA. The Extracellular Matrix Facts Book. San Diego, CA, USA: Academic Press Inc, 1994
38. von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol 1998; 91: 319-323
39. Böhlandt S, von Kaisenberg CS, Wewetzer C, Christ B, Nicolaides KH, Brand-Saberi B. Hyaluronic acid in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod 2000; 15: 1155-1158
40. Aliakbar S, Brown PR, Bidwell D, Nicolaides KH. Human erythrocyte superoxide dismutase in adults, neonates, and normal, hypoxaemic, anaemic, and chromosomally abnormal fetuses. Clin Biochem 1993; 26: 109-115
41. von Kaisenberg CS, Prols F, Nicolaides KH, Maass N, Brand-Saberi B. Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency. Human Reproduction 2003; 18: 2544-2561